Know Your AML Therapy: Venetoclax
Event Description
Venetoclax is an oral AML therapy that is becoming more commonly used in various combinations with other AML drugs. Learn it's mechanism of action, effectiveness and side effects from Dr. Mims and come with your questions.
Schedule & Agenda
Speakers & Moderators
Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors, and travel to new places.
Dr. Alice Mims is the Acute Leukemia Clinical Research Director and Associate Professor in the Division of Hematology at Ohio State University Comprehensive Cancer Center. Her research focuses on studying the effectiveness of novel therapeutics for patients with AML and other myeloid neoplasms including MDS.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
Get the latest thought leadership on your Acute Myeloid Leukemia delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.